JPS5872573A - Novel synthetic method for 2-guanidino-4-(2-(formamide) ethylthiomethyl)thiazole - Google Patents

Novel synthetic method for 2-guanidino-4-(2-(formamide) ethylthiomethyl)thiazole

Info

Publication number
JPS5872573A
JPS5872573A JP56172393A JP17239381A JPS5872573A JP S5872573 A JPS5872573 A JP S5872573A JP 56172393 A JP56172393 A JP 56172393A JP 17239381 A JP17239381 A JP 17239381A JP S5872573 A JPS5872573 A JP S5872573A
Authority
JP
Japan
Prior art keywords
guanidino
thiazole
ethylthiomethyl
formamide
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP56172393A
Other languages
Japanese (ja)
Other versions
JPH0141634B2 (en
Inventor
Kentaro Hirai
健太郎 平井
Shigeru Matsutani
茂 松谷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Priority to JP56172393A priority Critical patent/JPS5872573A/en
Publication of JPS5872573A publication Critical patent/JPS5872573A/en
Publication of JPH0141634B2 publication Critical patent/JPH0141634B2/ja
Granted legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

PURPOSE:2-Guanidino-4-[2-(N-protected formamide)ethylthiomethyl]thiazole is treated with an appropriate deprotecting agent to produce the titled compound used as a remedy for gastric ulcer in high yield. CONSTITUTION:The reaction of guanylthiourea with a compound of formula I(A is reactive group; R is protecting group) gives 2-guanidino-4-[2-(N-protected formamide)ethylthiomethyl]thiazole of formula II and the product is treated with a deprotecting agent such as trifluoroacetic acid, 85% sulfuric acid or 90% phosphoric acid to give 2-guanidino-4-[2-(fromamide)ethylthiomethyl]thiazole of formula III. USE:A drug showing an antagonistic action on himstamine H2.

Description

【発明の詳細な説明】 アミド)エチルチオメチルクチアゾールの新合成法に関
する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a new method for synthesizing amido)ethylthiomethylcutiazole.

本発明の要旨は.グアニルチオ尿素に 一般式 %式%() 〔式中.Aは反応性基.Rは保護基をそれぞれ表わす。The gist of the invention is as follows. to guanylthiourea general formula %formula%() [During the ceremony. A is a reactive group. Each R represents a protecting group.

〕 で示される化合物を反応させて2−グアニジノ−q−(
:x−(N−保護ホルムアミド)エチルチオメチル)チ
アゾール(n)を生成させ.次いで前記生成物を脱保護
剤と処理して2−グアニジノ−グーC2−Cホルムアミ
ド)エチルチオメチルクチアゾールを得る点にある。
] 2-guanidino-q-(
:x-(N-protected formamido)ethylthiomethyl)thiazole (n) is produced. The product is then treated with a deprotecting agent to obtain 2-guanidino-g-C2-Cformamido)ethylthiomethylcutiazole.

本発明方法は下記反応式で示される。The method of the present invention is shown by the following reaction formula.

〔式中、AおよびRはそれぞれ前記と同意義を有する。[In the formula, A and R each have the same meanings as above.

〕 上記定義において0反応性基としてはハロゲン(例えば
、塩素、臭素、ヨウ素)、スルホニルオキシ基(例えば
、トシルオキシ、メシルオキシ)など、保護基としては
1〜3アリール置換メチル基(例えば、トリチル、ベン
ズヒドリル、P−メトキシベンジル)がそ、れぞれ例示
される。
] In the above definition, zero-reactive groups include halogen (e.g., chlorine, bromine, iodine), sulfonyloxy groups (e.g., tosyloxy, mesyloxy), and protective groups include 1-3 aryl-substituted methyl groups (e.g., trityl, benzhydryl). , P-methoxybenzyl) are exemplified.

目的物質(1)はヒスタミン塩に対する拮抗作用を示し
、胃潰瘍の治療に有用である〔米国特許出願第114’
914号〕。しかしながら、その既存工業的製法は必ず
しも満足すべきものではない。
Target substance (1) exhibits an antagonistic effect on histamine salts and is useful for the treatment of gastric ulcers [US Patent Application No. 114'
No. 914]. However, existing industrial production methods are not necessarily satisfactory.

本発明方法の閉環反応は、グアニルチオ尿素とケトン(
ill)を適当な溶媒(例えば、アセトン、ジオキサン
、ジメチルポルムアミド、ジメチルスルホキシドなど)
中20−20θ°c、好ましくは使用スル溶媒の沸点程
度に加熱して実施すh;S。必要なら、トリエチルアミ
ン、ピリジンなどの塩基を添加してもよい。
The ring-closing reaction of the method of the present invention involves guanylthiourea and ketone (
ill) in a suitable solvent (e.g., acetone, dioxane, dimethylpolamide, dimethyl sulfoxide, etc.)
It is carried out by heating to a temperature of 20 to 20 θ°C, preferably around the boiling point of the solvent used. If necessary, a base such as triethylamine or pyridine may be added.

次いで、N−保護基の脱保護反応は適当な脱保護剤(例
えば、トリフルオロ酢M、I!;%硫酸。
The deprotection reaction of the N-protecting group is then carried out using a suitable deprotecting agent (eg, trifluoroacetic acid M, I!% sulfuric acid.

90%リン酸など)を使用し、θ6c〜!06c、好ま
しくは室温下に行われる。
90% phosphoric acid, etc.), θ6c~! 06c, preferably carried out at room temperature.

原料物質(1)は下記反応式で示されるように7スタミ
ンから容易に合成される: 〔式中、AおよびRは前記と同意義を有する。〕本本発
明法は両工程とも好収率下に進行し、目的物質(1)の
工業的合成法として好適である。
Raw material (1) is easily synthesized from 7stamine as shown in the following reaction formula: [wherein A and R have the same meanings as above. ] The method of the present invention proceeds with good yields in both steps, and is suitable as an industrial synthesis method for the target substance (1).

以下に本発明方法の実施例および参考例を示す。Examples and reference examples of the method of the present invention are shown below.

実施例1 N−ホルミル−N−トリチル−2−(3−クロルアセト
ニルチオ)エチルアミンタllrIIgおよびアセトン
/2mlからなる溶液にグアニルチオ尿素/33Mgを
加え、7f時間還流する。反応液を減圧濃縮し、粗製2
−グアニジノ−’l−C2−(N−トリチルホルムアミ
ド)エチルチオメチルフチアゾールを得る。これをトリ
フルオロ酢酸3mlに溶解し、3θ分間攪拌する。反応
液を減圧下に濃縮乾固し、残渣をメタノールに溶解し、
トリエチルアミンで塩基性とし、減圧濃縮する。得られ
る油状物をンリカゲルによるカラムクロマトグラフィー
に付し、酢酸エチル/メタノールl:/。
Example 1 Guanylthiourea/33Mg is added to a solution consisting of N-formyl-N-trityl-2-(3-chloroacetonylthio)ethylamine talrIIg and acetone/2ml and refluxed for 7f hours. The reaction solution was concentrated under reduced pressure to obtain crude 2
-guanidino-'l-C2-(N-tritylformamido)ethylthiomethylfuthiazole is obtained. This was dissolved in 3 ml of trifluoroacetic acid and stirred for 3θ minutes. The reaction solution was concentrated to dryness under reduced pressure, and the residue was dissolved in methanol.
Make basic with triethylamine and concentrate under reduced pressure. The resulting oil was subjected to column chromatography using phosphoric acid gel and ethyl acetate/methanol 1:/.

−へ)にて溶出し、溶出液を濃縮し、油状物として2−
グアニジノ−クー〔λ−(ホルムアミド)エチルチオメ
チルフチアゾール2391111を得る。
-), the eluate was concentrated, and the 2-
Guanidino-cou[λ-(formamido)ethylthiomethylfuthiazole 2391111 is obtained.

NMR(CDJOD) 、δ 3.73([1、,2H
)。
NMR (CDJOD), δ 3.73 ([1,,2H
).

413(8、/H)。413 (8, /H).

797(B、/H) マレイン酸塩、融点/グ乙〜lグざ°C元素公析 C,
H,3N、O8,・C,H40やとして計算値 c、3
ざJ9iH,弘jI!、iN、/ノロ乙;S、/701
r(%) 実験値 C,313;I:H,’1.’17.N、/l
り3rS、/1..7グ(%) c以下余白) 実施例ユ 炭酸カリウムl♂fおよびアセトン90m1からなる懸
濁液に−/3’CにてN−ホルミル−N−トリチルシス
テアミン3グfおよびアセトンl0m1からなる溶液の
約′ろ量を加えたのち、13−ジクロルアセトン1.9
gおよびアセトン20xlからなる溶液を一度に加える
。次いで、−7〜−5℃にて残りのN−ホルミル−N−
)リチルンステアミン溶液を20分間に滴下し、徐々に
室温に戻してグ時間攪拌する。沈澱物を枦去し、得られ
たN−ホルミルーN−)リチルー2−(3−クロルアセ
トニルチオ)エチルアミンを含むP液にグアニルチオ尿
素/、7IIを加え、/乙、f時間還流する・反応液を
減圧濃縮し、粗製2−グアニジノ−g−C2−(N−)
リチルホルムアミド)エチル千オメチル〕チアゾール1
91/を得る。これをトリフルオロ酢酸20 mlに溶
解し、室温下20分間攪拌する。反応液を減圧下に濃縮
乾固し、残渣をメタノール、!;Omlに溶解し、トリ
エチルアミンで塩基性とし、減圧濃縮する。残渣をシリ
カゲルによるカラムクロマトグラフィーに付し、酢酸エ
チル。
797 (B, /H) Maleate, melting point / guza °C elemental analysis C,
Calculated value as H, 3N, O8, ・C, H40 c, 3
ZaJ9iH, HirojI! ,iN,/Noro Otsu;S,/701
r (%) Experimental value C, 313; I:H, '1. '17. N, /l
ri3rS, /1. .. 7 g (%) (margin below c) Example: Into a suspension consisting of potassium carbonate l♂f and acetone 90 ml -/at 3'C, a solution consisting of N-formyl-N-tritylcysteamine 3 g f and acetone 10 ml was added. After adding approximately 1.9% of 13-dichloroacetone,
Add a solution consisting of g and 20xl of acetone all at once. Then, the remaining N-formyl-N-
) Add the richlensteamine solution dropwise over a period of 20 minutes, gradually return to room temperature, and stir for a period of time. The precipitate was removed, and guanylthiourea/7II was added to the obtained P solution containing N-formyl-N-)lithyl-2-(3-chloroacetonylthio)ethylamine, and refluxed for /f hours. Reaction. The liquid was concentrated under reduced pressure to obtain crude 2-guanidino-g-C2-(N-).
lythylformamide)ethylthiomethyl]thiazole 1
Get 91/. This was dissolved in 20 ml of trifluoroacetic acid and stirred at room temperature for 20 minutes. The reaction solution was concentrated to dryness under reduced pressure, and the residue was dissolved in methanol. Dissolve in Oml, make basic with triethylamine, and concentrate under reduced pressure. The residue was subjected to column chromatography on silica gel and ethyl acetate.

次いテ酢酸エチル/メタノール(Q:/、v/)にて溶
出する。溶出液を濃縮し、油状物とじて2−ゲアニジノ
ー’l−C2−(ホルムアミド)エチルチオメチルクチ
アゾール1rssyを得る。
Next, elute with ethyl theacetate/methanol (Q:/, v/). Concentrate the eluate to obtain 2-geanidino'l-C2-(formamido)ethylthiomethylcutiazole 1rssy as an oil.

実施例3 炭酸カリウムよOgおよびアセトン200 mlからな
る懸濁液に一20″CにてN−ホルミル−N −トリチ
ルシステアミン9t(/をアセトン220 mlからな
る溶液の約′ろ量を加えたのち、13−ジクロルアセト
ン乙Ogおよびアセトン’l0slからなる溶液を一度
に加える。反応液を室温に戻しながら、残りのN−ホル
ミル−N−トリチルシスタミン溶液を徐々に滴下し、2
時間攪拌する。沈澱物をP去し、得られるN−ホルミル
−N−)−リチルー2−(3−クロルアセトニルチオ)
エチルアミンを含むP液にグアニルチオ尿素lA♂fを
加え。
Example 3 After adding 9 t of N-formyl-N-tritylcysteamine (/) to a suspension consisting of 200 ml of potassium carbonate and 200 ml of acetone at -20''C, approximately the amount of a solution consisting of 220 ml of acetone was added. , 13-dichloroacetone Og and acetone'l0sl are added all at once.While the reaction solution is being returned to room temperature, the remaining N-formyl-N-tritylcystamine solution is gradually added dropwise.
Stir for an hour. The precipitate was removed and the resulting N-formyl-N-)-lythyl-2-(3-chloroacetonylthio)
Add guanylthiourea lA♂f to P solution containing ethylamine.

22時間還流する。反応液を減圧濃縮し、残渣に飽和炭
酸水素ナトリウム水溶液!;00m1−メタノール3m
lを加える。析出する結晶をP取し、クロロホルム−水
に分配する。有機層を無水芒硝で乾燥し、溶媒を留去し
、2−グアニジノ−弘−〔2−(N−1−リチルホルム
アミド)エチルチオメチルクチアゾール/l/1/を得
る。融点2!;3;”C以上(分解)(メタノールから
再結晶)。
Reflux for 22 hours. The reaction solution was concentrated under reduced pressure, and the residue was a saturated aqueous sodium hydrogen carbonate solution! ;00ml 1-methanol 3m
Add l. The precipitated crystals are collected and distributed between chloroform and water. The organic layer is dried over anhydrous sodium sulfate and the solvent is distilled off to obtain 2-guanidino-hiro-[2-(N-1-lythylformamido)ethylthiomethylcutiazole/l/1/. Melting point 2! ;3;"C or higher (decomposition) (recrystallized from methanol).

NMR(d−DMSO)、  δ  乙ノア(br、s
、4/H)。
NMR (d-DMSO), δ otonoa (br, s
, 4/H).

727 (br、 8. /乙H)。727 (br, 8./Otsu H).

!37(8、/H) 元素分析cA7N、os2トシテ 計算値 C,6弘64にH,まグ3’、N、/3.9t
! 37 (8, /H) Elemental analysis cA7N, os2 calculation value C, 6hiro64 H, mag 3', N, /3.9t
.

S、/17J’(%) 実験値 C,41Aj6i H,3J3 iN、 /3
.76 iS、/、2.51%) b)Trt 2−グアニジノ−グーC2−(N−トリチルポルムアミ
ド)エチルチオメチ当〕チアゾ−Jし3sgにtS%硫
酸9 mlを加え、室温下に2θ分間攪拌する。反応液
を飽和炭酸水素ナトリウム液に注入して中和し、酢酸エ
チルと振とうする。水層を減圧濃縮し、残渣をメタノー
ルで抽出する。メ・タノール抽出液から溶媒を留去し、
残渣をシリカゲルによるカラムクロマトグラフィーに付
し、酢酸エチル−メタノール(44: / 、 v/v
’)で溶出する。
S, /17J' (%) Experimental value C,41Aj6i H,3J3 iN, /3
.. 76 iS, /, 2.51%) b) Trt 2-guanidino-g C2-(N-tritylporumamido)ethylthiomethythyl]thiazo-J, add 9 ml of tS% sulfuric acid to 3 sg, and stir at room temperature for 2θ minutes. do. The reaction solution is neutralized by pouring into saturated sodium bicarbonate solution and shaken with ethyl acetate. The aqueous layer is concentrated under reduced pressure, and the residue is extracted with methanol. The solvent is distilled off from the methanol extract,
The residue was subjected to column chromatography on silica gel, and ethyl acetate-methanol (44:/, v/v
').

溶出液を濃縮し、油状物としてコーゲアニジノー#−C
2−(ホルムアミド)エチルチオメチJし〕チアゾール
’It/ηを得る。マレイン酸塩、融点/IA〜/lI
l°c。
Concentrate the eluate and extract Kogeanidino #-C as an oil.
2-(formamido)ethylthiomethane]thiazole'It/η is obtained. Maleate salt, melting point /IA ~ /lI
l°c.

実施例弘 脱保護剤として90%リン酸を使用し、実施例3(b)
の反応を行い、同様の収率で2−グアニドノー+−C2
−(ホルムアミド)エチlレチオメチル〕チアゾールを
得る。
Example Hiro Using 90% phosphoric acid as the deprotecting agent, Example 3(b)
The reaction was carried out to give 2-guanidono+-C2 with similar yield.
-(formamido)ethyl-rethiomethyl]thiazole is obtained.

a)金属ナトリウム12f/およびエタノールlOθ献
からなる溶液にシスタεンニ塩酸塩it、31を加え、
jθ〜乙O″Cで1時間攪拌する。エタノールを減圧留
去し、残渣にギ酸エチル!;Omlを加え。
a) Adding cystane dihydrochloride it, 31 to a solution consisting of metallic sodium 12f/and ethanol lOθ,
The mixture was stirred for 1 hour at a temperature of 0 to 0. Ethanol was distilled off under reduced pressure, and 0 ml of ethyl formate was added to the residue.

弘時間還流する。冷後1反応液にメタノールjOmlを
加え、析出する塩化ナトリウムを枦去し、P液を減圧濃
縮する。残渣をシリカゲルによるカラムクロマトグラフ
ィーに付し、酢酸エチル/メタノール(10: / 、
 v/v、)にて溶出する。溶出液を濃縮し、無色油状
物としてN、N’−ジホルミルシスタミン2.91を得
る。
Kojiki reflux. After cooling, add 1 Oml of methanol to the reaction solution to remove the precipitated sodium chloride, and concentrate the P solution under reduced pressure. The residue was subjected to column chromatography on silica gel using ethyl acetate/methanol (10:/,
Elute at v/v, ). Concentrate the eluate to obtain 2.91 N,N'-diformylcystamine as a colorless oil.

NMR(CDjOD)、δ Qr3(t 、J=6Hz
 、2H)。
NMR (CDjOD), δ Qr3(t, J=6Hz
, 2H).

3.3; 3 (t 、 J=gHz 、 、2H) 
3.3; 3 (t, J=gHz, , 2H)
.

’Z91(s、/H) b)ンスタミンニ塩酸塩jjgおよびギ酸エチル1.0
mlからなる懸濁液にトリエチルアミン10fを加え、
5時間還流する。冷後、沈澱物を炉去し。
'Z91 (s, /H) b) Nstamine dihydrochloride jjjg and ethyl formate 1.0
Add 10f of triethylamine to the suspension consisting of ml,
Reflux for 5 hours. After cooling, the precipitate was removed from the oven.

P液を減圧濃縮する。残渣をシリカゲルによるカラムク
ロマトグラフィーに付し、酢酸エチル/メタノール(1
0:/、v/)にて溶出する。溶出液を濃縮し、油状物
としてN、N’−ジホルミルシスタミン3乙fを得る。
Concentrate the P solution under reduced pressure. The residue was subjected to column chromatography on silica gel and ethyl acetate/methanol (1
Elute at 0:/, v/). Concentrate the eluate to obtain N,N'-diformylcystamine 3f as an oil.

参考例2 N、N’−ジホルミルシスタミン4jllllf、塩化
トリチル/92111f/および乾燥アセトニトリルl
曹lからなる懸濁液にトリエチルアミン700119を
加え。
Reference Example 2 N,N'-diformylcystamine 4jllllf, trityl chloride/92111f/ and dry acetonitrile l
Add triethylamine 700119 to a suspension consisting of sodium bicarbonate.

室温下に3時間攪拌する。析出する結晶を戸数し。Stir at room temperature for 3 hours. Count the number of crystals that precipitate.

少量のアセトニトリルで洗浄し、水洗し、乾燥してN、
N’−ジホルミル−N 、 N’−ジトリチルシスタミ
ン/7!;IIIを得る。融点277〜2/r”c(ク
ロロホルム−エタノール)。
Wash with a small amount of acetonitrile, water, dry, and
N'-diformyl-N, N'-ditritylcystamine/7! ; obtain III. Melting point 277-2/r"c (chloroform-ethanol).

元素分析 C□H,、NユOユSユ・として計算値 c
、7乙、24iH,ま♂2jN、1A0117S、92
1.C%) 実験値 c、7乙JJ’;H,J:44;N、JJ’り
;S、9//(%) 参考例3 N、N−ジホルミル−N、N−ジトリチルシスタミン3
.’llおよび塩化メチレン!;Oxlからなる溶液に
水jmlおよびトリブチルホスフィン179を順次加え
、1時間攪拌下に還流する。冷後、有機層を分離し、無
水芒硝で乾燥し、減圧濃縮する。
Elemental analysis Calculated value as C□H,,NyuOyuSyu・c
, 7 Otsu, 24iH, Ma♂2jN, 1A0117S, 92
1. C%) Experimental value c, 7 JJ'; H, J: 44; N, JJ'; S, 9 // (%) Reference example 3 N, N-diformyl-N, N-ditritylcystamine 3
.. 'll and methylene chloride! ;Jml of water and 179 ml of tributylphosphine are sequentially added to the solution consisting of Oxl, and the mixture is refluxed for 1 hour while stirring. After cooling, the organic layer is separated, dried over anhydrous sodium sulfate, and concentrated under reduced pressure.

残渣をエタノールより再結晶し、融点16j〜l乙7@
Cの結晶としてN−ホルミル−N−)リチルシステアミ
ン2..7331を得る。収率93%。
The residue was recrystallized from ethanol to give a melting point of 16j~lOtsu7@
N-formyl-N-)lythylcysteamine as crystals of C2. .. Get 7331. Yield 93%.

元素分析 C2ユH,、NO8として 計算値 C,7t、θ& i H、4,C9i N 、
 lAθ3;8.923(%) 実験値 C,76,09,H,より3;:N、3.ざ2
;8 、937. (%) IR,、Nu J O’  t 6s t cMax 参考例ψ シスタミンニ塩酸塩229およびギ酸エチJし3θOs
lからなる懸濁液にトリエチJレアミンjθfを加え、
6時間還流する。ギ酸エチJし/!;0*1を常圧で留
去し、新たに蒸留したギ酸エチJし130m1を加え、
2時間還流する。冷後、白色沈澱物を枦去し、P液を濃
縮する。残渣を酢酸エチJし/ア士トニトリル(/ :
 / 、 v/v) Iこ溶解し、不溶物をP去する。
Elemental analysis C2UH,, Calculated value as NO8 C,7t,θ&iH,4,C9iN,
lAθ3; 8.923 (%) Experimental value C, 76,09, H, 3;: N, 3. The 2
;8,937. (%) IR,, Nu J O' t 6s t cMax Reference example ψ Cystamine dihydrochloride 229 and ethyl formate J and 3θOs
Add triethyl J raremin jθf to the suspension consisting of
Reflux for 6 hours. Formic acid ethi Jshi/! Distill 0*1 at normal pressure, add 130ml of freshly distilled ethyl formic acid,
Reflux for 2 hours. After cooling, remove the white precipitate and concentrate the P solution. The residue was diluted with ethyl acetate/ethyl nitrile (/:
/, v/v) I and insoluble materials are removed.

F液を減圧濃縮し、油状物としてN。Concentrate solution F under reduced pressure to obtain N as an oil.

N′−ジホルミルシスタミン21A9 flを得る。こ
れを乾燥アセトニトリJし2!;0xliこ溶解し、塩
化トリチルjlA2gおよびトリエチJレアミン2/f
/を加え、室温下に6時間攪拌する。析出する結晶を炉
取し、エタノールで洗浄し、 N 、 N’−ジホルε
ルーN、N−ジトリチルシスタミンを得る。これを塩化
メチレン3θOmlに溶解し、水SO献およびトリブチ
ルホスフィン/i31を加え、7時間加熱攪拌する。冷
浸、有機層を分離し、無水芒硝で乾燥し、減圧濃縮する
。残渣をエタノールで洗浄してN−、ホルミル−N−ト
リチルシステアミングsyを得る。融点l乙j〜/乙7
°C0参考例5 り 炭酸カリウムjOθqおよびアセトン2θlll1から
なる懸濁液に−j℃にて13−ジクロルアセトン23/
llf/を加え、激しく攪拌しながらN−ホルミル−N
、−)リチルシステアミン、f73;H1およびアセト
ン30m1からなる溶液を30分間にて滴下し、30分
間θ°Cで攪拌する。沈澱物を枦去し。
N'-diformylcystamine 21A9 fl is obtained. Dry this with acetonitrile J2! ;0xli dissolved, trityl chloride jlA 2g and triethyl chloride JlA 2/f
/ and stirred at room temperature for 6 hours. The precipitated crystals were collected in a furnace and washed with ethanol to give N, N'-diform ε
Roux N,N-ditritylcystamine is obtained. This was dissolved in 3θOml of methylene chloride, water, SO and tributylphosphine/i31 were added, and the mixture was heated and stirred for 7 hours. After cooling, the organic layer was separated, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue is washed with ethanol to obtain N-,formyl-N-tritylcysteaming sy. Melting point l Otsuj~/Otsu7
°C0 Reference Example 5 13-dichloroacetone 23/
llf/ and N-formyl-N with vigorous stirring.
,-) Lythyl cysteamine, f73; A solution consisting of H1 and 30 ml of acetone was added dropwise over 30 minutes and stirred at θ°C for 30 minutes. Remove the precipitate.

炉液を減圧濃縮する。残渣をクロロホルムに溶解し、水
洗し、無水芒硝で乾燥し、濃縮する。得られる油状物を
シリカゲルによるカラムクロマトグラフィーに付し、ベ
ンゼン/酢酸エチJしく70:t、v/)&tで溶出す
る。溶出液を濃縮し、油状■ 物としてN−ホルミル−N−)リチJレ−2−(3−ク
ロルアセトニルチオ)エチルアミンg+♂q4得る。
Concentrate the furnace liquid under reduced pressure. The residue is dissolved in chloroform, washed with water, dried over anhydrous sodium sulfate, and concentrated. The resulting oil is subjected to column chromatography on silica gel, eluting with benzene/ethyl acetate (70:t, v/)&t. The eluate was concentrated to obtain N-formyl-N-)lithium-2-(3-chloroacetonylthio)ethylamine g+♂q4 as an oily substance.

NMfL(CDCA  ) 、δ 3ユj(s、2H)
NMfL(CDCA), δ 3yuj(s, 2H)
.

1A/J(s、2H)。1A/J (s, 2H).

723(d、/3H’)。723(d, /3H').

ざJ、5’(’8./H)ZaJ, 5' ('8./H)

Claims (2)

【特許請求の範囲】[Claims] (1)2−グアニジノーダーC2−(N−保護ホルムア
ミド)エチル千オメチル〕チアゾールを脱保護剤と処理
することを特徴とする2−グアニジノ−4!−(2−(
ホルムアミド)エチルチオメチJし〕チアゾールの“新
合成法。
(1) 2-guanidino-4 characterized by treating 2-guanidinoder C2-(N-protected formamide)ethylthiomethyl]thiazole with a deprotecting agent! -(2-(
A new synthesis method for thiazole (formamide)ethylthiomethyazole.
(2)グアニルチオ尿素に一般式 %式%) 〔式中、Aは反応性基、Rは保護基をそれぞれ表わす。 〕 で示される化合物を反応させて2−グアニジノ−+−C
2−(N−保護ホルムアミド)エチルチオメチルクチア
ゾールを生成させ1次いで前記生成物を脱保護剤と処理
することを特徴とする2−グアニジノ−4!−C2−(
ホルムアミド)エチJレチォメチル〕チアゾールの新合
成法。
(2) Guanylthiourea has the general formula % (% formula %) [In the formula, A represents a reactive group and R represents a protective group, respectively. ] 2-guanidino-+-C by reacting the compound represented by
2-guanidino-4!, characterized in that 2-(N-protected formamido)ethylthiomethylcutiazole is produced and then the product is treated with a deprotecting agent. -C2-(
A new synthesis method for (formamide) ethylthiazole.
JP56172393A 1981-10-27 1981-10-27 Novel synthetic method for 2-guanidino-4-(2-(formamide) ethylthiomethyl)thiazole Granted JPS5872573A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP56172393A JPS5872573A (en) 1981-10-27 1981-10-27 Novel synthetic method for 2-guanidino-4-(2-(formamide) ethylthiomethyl)thiazole

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56172393A JPS5872573A (en) 1981-10-27 1981-10-27 Novel synthetic method for 2-guanidino-4-(2-(formamide) ethylthiomethyl)thiazole

Publications (2)

Publication Number Publication Date
JPS5872573A true JPS5872573A (en) 1983-04-30
JPH0141634B2 JPH0141634B2 (en) 1989-09-06

Family

ID=15941094

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56172393A Granted JPS5872573A (en) 1981-10-27 1981-10-27 Novel synthetic method for 2-guanidino-4-(2-(formamide) ethylthiomethyl)thiazole

Country Status (1)

Country Link
JP (1) JPS5872573A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022034121A1 (en) 2020-08-11 2022-02-17 Université De Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022034121A1 (en) 2020-08-11 2022-02-17 Université De Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Also Published As

Publication number Publication date
JPH0141634B2 (en) 1989-09-06

Similar Documents

Publication Publication Date Title
JPS635389B2 (en)
CN114805314A (en) Synthesis method of Ensaitevir
Campaigne et al. Thiazoles and thiadiazines. The condensation of ethyl 4‐chloroacetoacetate with thiosemicarbazide
SU640662A3 (en) Method of obtaining imidazole derivatives or salts thereof
CA2069667A1 (en) Leukotriene b4 antagonist
JPS5872573A (en) Novel synthetic method for 2-guanidino-4-(2-(formamide) ethylthiomethyl)thiazole
US5089616A (en) Process for the preparation of [1S-(1R*,2S*,3R*)]-N-(4-morpholinylsulfonyl)-L-phenylalanyl-3-(2-amino-4-thiazolyl-N-[(1-cyclohexylmethyl)-2,3-dihydroxy-5-methylhexyl]-L-alaninamide
CN108191849B (en) Preparation method of anti-epidermal growth factor receptor drug resistance mutation inhibitor, related intermediate and application
JPS5916871A (en) Sulfonamide-based benzamides
JPH0579061B2 (en)
EP3915984A1 (en) SYNTHESIS OF 3-BROMO-5-(2-ETHYLIMIDAZO[1,2-alpha]PYRIDINE-3-CARBONYL)-2-HYDROXYBENZONITRILE
JPH0260667B2 (en)
NO177495B (en) Analogous Process for Preparation of Therapeutically Active Glycerine Derivatives
US4254259A (en) 2-Amino-5-ethylovalyl-6H-1,3,4-thiadiazine oxime
JPS5944312B2 (en) Production method of indazole derivatives
CN111233857B (en) Synthetic method for continuously producing pexidininib
US2816892A (en) Pyridazinesulfonamides
JPS60100557A (en) Preparation of guanidine derivative
US3560514A (en) 2-(lithiummethyl)-4,5-dianisylthiazole
JPS5935400B2 (en) Method for producing 5-nitroimidazole derivative
KR860000591B1 (en) Process for preparing pyridine carboxylic acid derivatives
Shafiee et al. Synthesis of 2‐aryl‐6‐carbethoxythiazolo [4, 5‐c] pyridine and 7‐chloro‐2‐phenylthiazolo [5, 4‐c] pyridine
SU1243623A3 (en) Method of producing derivatives of 1,2,5-thiadizole
JPS5814438B2 (en) Pyrazolopyridine
PL164340B1 (en) Method of obtaining novel benzothiazine derivatives